30 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties.

Ataturk University
Synthesis of donepezil-based multifunctional agents for the treatment of Alzheimer's disease.

Ataturk University
N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II.

Ataturk University
Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors.

Ataturk University
Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols and their derivatives including natural products: vidalol B.

Ataturk University
In vitro inhibition of human erythrocyte glutathione reductase by some new organic nitrates.

Ataturk University
A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies.

Ataturk University
NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and II.

Ataturk University
Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.

Ataturk University
In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.

Ataturk University
Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides.

Ataturk University
Design, synthesis and biological evaluation of 3,5-diaryl isoxazole derivatives as potential anticancer agents.

Ataturk University
Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine.

Ataturk University
Heterocyclic inhibitors of glutaminase

Calithera Biosciences
Compounds as cannabinoid receptor ligands

Abbvie
Pyrazine derivatives and use as PI3K inhibitors

Merck Serono
Identification of stabilizers of multimeric proteins

The Leland Stanford Junior University
Oxazine derivatives and their use in the treatment of neurological disorders

Novartis
Triazole compounds that modulate HSP90 activity

Synta Pharmaceuticals
Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases

Astex Therapeutics
Synthesis of (glycopyranosyl-triazolyl)-purines and their inhibitory activities against protein tyrosine phosphatase 1B (PTP1B).

East China University of Science and Technology
Inhibitors of PI3 kinase and/or mTOR

Amgen
Aminopyrazoloquinazolines

Boehringer Ingelheim International
Inhibitors of PI3 kinase

Amgen
GSK-3 inhibitors

Neuropharma
Prolylcarboxypeptidase inhibitors

Merck Sharp & Dohme
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

Merck Frosst Centre For Therapeutic Research
Cloning and characterization of the rat 5-HT5B receptor. Evidence that the 5-HT5B receptor couples to a G protein in mammalian cell membranes.

University of Heidelberg Zmbh
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models.

Abbott Laboratories